Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-055779
Filing Date
2021-09-13
Accepted
2021-09-13 20:12:26
Documents
2
Period of Report
2021-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1589
2 POA DOCUMENT poa.txt EX-24.3_1008143 3101
  Complete submission text file 0001209191-21-055779.txt   5992
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Issuer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JEW JEANNE Y (Reporting) CIK: 0001235946 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51173 | Film No.: 211250954